Logo

Gene Security Network Raises $6M

Jan 07, 2009
NEW YORK (GenomeWeb News) – Molecular diagnostics firm Gene Security Network has closed a $6 million Series B round of financing, the Redwood City, Calif.-based firm said today.
 
The company is developing its Parental Support technology, which uses data informatics to deliver single-cell testing for chromosome abnormalities and genetic diseases. GSN also operates a CLIA-certified lab in California, providing testing services to help guide physicians in selecting embryos during in vitro fertilization.
 
“Our technology will enable a host of services that make genetic information actionable, so that doctors worldwide can order tests to improve the quality of life for their patients,” GSN President and CEO Matthew Rabinowitz said in a statement.
 
The firm’s existing investors, Claremont Creek Ventures and Sequoia Capital, participated in the round of financing along with new investor Alafi Capital.

Filed under

Diagnostics
Informatics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.